National Institutes of Health. NIH. Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research.. Fed Register 1994; 59:14508–14513. https://grants.nih.gov/grants/guide/notice-files/not94-100.html#:~:text=guidelines%20on%20the%20inclusion%20of%20women%20and%20minorities,Act%20of%201993.%20EFFECTIVE%20DATE%3A%20March%209%2C%201994
Labots G, et al. Gender differences in clinical registration trials: Is there a real problem? Br J Clin Pharmacol 2018; 84:700–707. doi: 10.1111/bcp.13497
Pilote L, Raparelli V. Participation of women in clinical trials: Not yet time to rest on our laurels. J Am Coll Cardiol 2018; 71:1970–1972. doi: 10.1016/j.jacc.2018.02.069
Bairey Merz CN, et al. Sex and the kidneys: Current understanding and research opportunities. Nat Rev Nephrol 2019; 15:776–783. doi: 10.1038/s41581-019-0208-6
National Institutes of Health. Consideration of sex as a variable in NIH funded research. June 9, 2015. Notice number NOT-OD-15-102. https://grants.nih.gov/grants/guide/notice-files/not-od-15-102.html
Institute of Medicine (US) Committee on Understanding the Biology of Sex and Gender Differences; Wizemann TM, Pardue ML, editors. Exploring the Biological Contributions to Human Health: Does Sex Matter? Washington, DC, National Academies Press, 2001. https://www.ncbi.nlm.nih.gov/books/NBK222288/
Neugarten J, Golestaneh L. Influence of sex on the progression of chronic kidney disease. Mayo Clin Proc 2019; 94:1339–1356. doi: 10.1016/j.mayocp.2018.12.024
Ricardo AC, et al. Sex-related disparities in CKD progression. J Am Soc Nephrol 2019; 30:137–146. doi: 10.1681/ASN.2018030296
Gohar EY, et al. Evidence for G-protein-coupled estrogen receptor as a pronatriuretic factor. J Am Heart Assoc 2020; 18;9(10):e015110. doi: 10.1161/JAHA.119.015110
Mitchell T, et al. Sex differences in redox homeostasis in renal disease. Redox Biol 2020; 101489. doi: 10.1016/j.redox.2020.101489
Lobo RA. Where are we 10 years after the Women's Health Initiative? J Clin Endocrinol Metab 2013; 98:1771–1780. doi: 10.1210/jc.2012-4070
Parekh A, et al. Adverse effects in women: Implications for drug development and regulatory policies. Expert Rev Clin Pharmacol 2011; 4:453–466. doi: 10.1586/ecp.11.29